Kiley Juergens Wealth Management’s Charles River Laboratories CRL Stock Holding History

Kiley Juergens Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-143	Closed	-$19K	–	161
2018 Q3	$19K	Hold	143	–	–	0.01%	365
2018 Q2	$16K	Buy	+143	New	+$15.5K	0.01%	360
2018 Q1	–	Sell	-143	Closed	-$15K	–	188
2017 Q4	$15K	Buy	+143	New	+$15.6K	0.01%	393

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Kiley Juergens Wealth Management's CRL Position: Q4 2018 in Review

Kiley Juergens Wealth Management sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 143 shares — an estimated $19K sold.

Kiley Juergens Wealth Management first reported a position in CRL in Q4 2017 and held it in 3 quarters. The position peaked at $19K in Q3 2018. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

Kiley Juergens Wealth Management reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
Kiley Juergens Wealth Management sold 143 Charles River Laboratories shares in Q4 2018, an estimated $19K.
Kiley Juergens Wealth Management first reported a position in Charles River Laboratories in Q4 2017 and held it in 3 quarters.
Kiley Juergens Wealth Management's Charles River Laboratories position peaked at $19K in Q3 2018.
407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on Kiley Juergens Wealth Management's 13F filing for Q4 2018, filed 15 Jan 2019.